Delivery Order SPE2DB20D3101-SPE2DB23FRYD4

Award Date 9/19/23
Potential Completion Date 9/20/23
Potential Value $1.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $3,402.85 for the supply of 4553868518 - DEXMETHYLPHENIDATE ER 25 MG CP 100S. The contract was awarded on June 14, 2021 by the Defense Logistics Agency (DLA), a defense agency, with a completion date of June 15, 2021. The contract is a Firm Fixed Price Delivery Order and was not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug...
This federal contract award, valued at $1,097.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXMETHYLPHENIDATE ER 10 MG CP 100S, a pharmaceutical product. The contract is a Delivery Order and has a Firm Fixed Price pricing type, with a period of performance through February 5, 2025. This contract award is not associated with a set-aside designation....
This federal contract award, valued at $3,014.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,373,469 units of DEXMETHYLPHENIDATE ER 20 MG CP, a generic pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of November 8, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $2,042.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,557,785,231 units of Dexmethylphenidate ER 25 mg capsules. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,556,004,424 units of Dexmethylphenidate ER 10 mg Capsules. The firm-fixed-price Delivery Order, valued at $1,008.40, has a completion date of January 21, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,164,745 units of the drug dexmethylphenidate ER 20 mg. The $1,533.78 firm fixed-price contract has an ultimate completion date of October 22, 2024. The contract is a delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen maintains a $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $1,206.14, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4567105441 - DEXMETHYLPHENIDATE ER 25 MG CP 100S, a pharmaceutical product, with a period of performance through January 31, 2025. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the parent company AmerisourceBergen Corporation. The contract is for the supply of 4,564,184,989 units of the pharmaceutical product DEXMETHYLPHENIDATE ER 20 MG CP 100S. The award has a ceiling value of $4,381.42 and a period of performance through April 8, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by...
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $1,258.08, is for the delivery of 4564631354 - DEXMETHYLPHENIDATE ER 15 MG CP 100S. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and was awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of May 17, 2024....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,103.69, is for the delivery of 4,563,152,813 units of DEXMETHYLPHENIDATE ER 15 MG CP. The contract has an ultimate completion date of December 21, 2023 and is a Firm Fixed Price Delivery Order. This award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRYD4
    Delivery Order

This federal contract award, valued at $1,123.28, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,267,389 units of the pharmaceutical product DEXMETHYLPHENIDATE ER 35 MG CP. This is a firm fixed-price delivery order contract with a completion date of September 20, 2023. The contract was awarded without any set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. Additionally, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical commodities.

Generated 2/27/25, 10:17 AM